Mental Processes Clinical Trial
— POM-03Official title:
Investigation of the Acute Effect of Pomegranate Extract on Cognitive Function in Human Volunteers: A Double-blind, Placebo-controlled, Crossover Trial
Verified date | October 2016 |
Source | Queen Margaret University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United Kingdom: Research Ethics Committee |
Study type | Interventional |
The double-blinded, randomised, placebo-controlled crossover pilot study is conducted as a
two week intervention after a pre-intervention registration and preparation period.
This study explores whether acute supplementation with pomegranate extract can modulate
indicators of cognitive function and mood in healthy adults. Changes in physiological and
biochemical markers are also investigated.
Status | Completed |
Enrollment | 20 |
Est. completion date | September 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Healthy - Aged 18-65 - Enjoy computer tasks Exclusion Criteria: - Diagnosis with any neurological, psychiatric or significant medical condition which could affect cognitive function - Known cognitive impairment - Use of any prescription, herbal or recreational drugs - Gastrointestinal disease - Pregnancy or breastfeeding - Pomegranate allergy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United Kingdom | Queen Margaret University | Edinburgh | Scotland |
Lead Sponsor | Collaborator |
---|---|
Angela Stockton | Northumbria University |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Simple reaction time (attention and vigilance, speed of attention) | Reaction time in msec. | 1-2 hours | No |
Primary | Choice reaction time (attention and vigilance, speed and accuracy of attention) | Arrows pointing left and right will appear on the screen at irregular intervals. The participant is required to indicate the direction of the arrow as quickly as possible, whenever an arrow is displayed. Measured by % accuracy, overall correct responses and reaction time (ms). | 1-2 hours | No |
Primary | Bond Lader mood scales | Mood is measured via the Bond Lader series of mood scales, each scored out of 100. From these scales three composite scores are calculated describing feelings of 'Alert', 'Calm' and 'Content', also presented as a score out of 100. | 1-2 hours | No |
Primary | Digit vigilance (attention and vigilance, speed and accuracy of attention) | A fixed number will appear on the right of the screen and a series of changing numbers will appear on the left side of the screen. Participants are required to make a response when the number on the left matches the number on the right. Measured by reaction time (ms) and %accuracy of responses. | 1-2 hours | No |
Primary | Word presentation (secondary memory) then delayed Word recall (quality of memory) | A list of words is displayed on the screen, one word at a time. Participants are given 60 seconds to write down as many of the words they were shown earlier as they can. This task was performed following following a delay between the presentation and recall (delayed recall). no of correct responses and % accuracy. | 1-2 hours | No |
Primary | Word recognition (secondary memory, quality and speed of memory) | All target words that were shown during Word Presentation plus an equal number of decoys will be displayed on the screen one at a time. Participants indicate if they remember seeing the word earlier or not. measured by correct no of responses, errors and reaction time (ms). | 1-2 hours | No |
Primary | Rapid Visual Information Processing (RVIP) (cognitive demand) | A series of numbers are displayed individually on the screen in quick succession (at a rate of 100 numbers per minute) and participants are required to respond when they see 3 odd numbers in a row or three even numbers in a row. Measured by % accuracy, no of false alarms and reaction time (ms). | 1-2 hours | No |
Primary | Picture presentation (secondary memory) and delayed recognition(secondary memory, speed and quality of memory) | A series of pictures are displayed on the screen, one at a time. After a delay, all target pictures shown during Picture Presentation plus an equal number of decoys will be displayed on the screen one at a time. For each stimulus participants select 'Yes' or 'No' to indicate if they have seen the picture before or not. The task is measured by reaction time (ms), % accuracy and no of correct responses. | 1-2 hours | No |
Primary | Corsi blocks lite (working memory, spatial memory) | Blue squares on a black background are displayed on the screen. Some of them change to red and back to blue again in a sequence. Participants are required to remember this sequence. The task is repeated five times at each level of difficulty with the sequence span increasing from 4 upwards, until the participant can no longer correctly recall the sequences. The task continues up to 6 squares in each sequence, while participants make enough correct responses. As soon as they make less than 3 correct responses (out of the five in one level) the task will end. All participants complete levels 4-6 regardless of incorrect responses. Results are measured by a span score: This score is calculated as the average of the last 3 correctly completed trials. For example, if the participant correctly responds to all five Level 4 trials and only one Level 5 trial, their span score would be 4.3 [(4 + 4 + 5)/3]. | 1-2 hours | No |
Secondary | Pre and post blood pressure changes | Measurement of systolic and diastolic blood pressure in mmHg. | 1-2 hours | No |
Secondary | Pre-post cortisol and cortisone changes | Collection of saliva which is processed via ELISA to measure cortisol and cortisone in ng/mL | 3-4 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05322343 -
Biobank and Brain Health in Bordeaux.
|
||
Completed |
NCT01632813 -
Leuven Growing Into Deficit Follow-up Study
|
N/A | |
Active, not recruiting |
NCT06309914 -
The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States
|
N/A | |
Active, not recruiting |
NCT03030053 -
The Effects of Flavonoid Supplementation on Cognition and Neural Mechanisms in Healthy Older Adults
|
N/A |